Status:

COMPLETED

Adherence Monitoring For Substance Abuse Clinical Trials

Lead Sponsor:

California Pacific Medical Center Research Institute

Collaborating Sponsors:

Creare, Inc.

Conditions:

Medication Adherence

Eligibility:

All Genders

18-60 years

Brief Summary

The purpose of this study is to determine the feasibility and accuracy of an automated adherence monitoring system, and to compare the variance between urine and oral fluid riboflavin levels when spec...

Eligibility Criteria

Inclusion

  • Male or female, aged 18 to 60
  • Ability to give informed consent.
  • Be willing and able to use the study-provided phone for taking and transmitting capsule photos.

Exclusion

  • Unwilling or unable to use a cell phone.
  • Any medical, psychiatric, or other condition that, in the opinion of the investigator, would preclude safe, consistent, or useful participation in the study.

Key Trial Info

Start Date :

January 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 1 2013

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT01867476

Start Date

January 1 2013

End Date

February 1 2013

Last Update

June 4 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Addiction & Pharmacology Research Lab, St. Luke's Hospital

San Francisco, California, United States, 94110

Adherence Monitoring For Substance Abuse Clinical Trials | DecenTrialz